Byetta Pancreatic and Kidney Injuries
Byetta is an injectable drug used to control blood sugar levels in patients with Type 2 diabetes. It acts by lowering post-meal and fasting glucose levels and is often prescribed to patients who have struggled to maintain their blood sugar levels using oral diabetes medications. Since entering the market in 2005, more than 6 million Byetta prescriptions have been dispensed.
While Byetta has helped many diabetics get their blood sugar under control, it has also placed them at serious risk of life-threatening conditions. Byetta has been associated with pancreatic and kidney injuries such as:
- Acute pancreatitis
- Acute renal failure
- Renal insufficiency
Acute pancreatitis is an inflammation of the pancreas which is accompanied by symptoms such as nausea, vomiting, and severe abdominal pain. Currently, the FDA has received 40 reports of patients developing acute pancreatitis after taking Byetta. Six of these cases were fatal. As a result, the FDA is considering placing a “black box” warning on the drug, which is the strongest warning issued for dangerous drugs.
The FDA has also received 78 reports of life-threatening kidney conditions associated with Byetta:
- 62 cases of acute renal failure (sudden and severe loss of kidney function)
- 16 cases of renal insufficiency (diminished ability of kidneys to remove waste from the body)
Of these 78 cases, 91% required hospitalization. There were 18 patients needing dialysis, two patients needing kidney transplants, and four patients who died from their kidney condition.
If you have developed a serious pancreatic or kidney injury from taking Byetta, you may be entitled to receive compensation for your damages. It is important to consult an experienced pharmaceutical injury lawyer who can help you with the filing of your claim.